Lastly, HFD APP/PS1 mice demonstrate elevated cognitive deficits, neuroinflammation, and Alzheimer’s disease markers such as amyloid-β (Xiao et al., 2022). Here, APP is linked to early-onset autosomal dominant Alzheimer disease.